Cann Group (ASX:CAN) to purchase Satipharm, drops revenue guidance

Retrieved on: 2021-02-15 02:03:45

Tags for this article:

Click the tags to see associated articles and topics

Cann Group (ASX:CAN) to purchase Satipharm, drops revenue guidance. View article details on hiswai:

Excerpt

Cann plans to have CBD Gelpell approved for sale in Australia and ... THC prescription formulations of medicinal cannabis," Peter told the market.

Article found on: themarketherald.com.au